Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy
A Tiersten, L B Saltz
Oncology Reports
|
May 21, 2011
Acute hypertensive crisis following octreotide administration in a patient with malignant pheochromocytoma
L Saltz, A Tiersten, B Hassan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer
A D Seidman, A Tiersten, C Hudis, et al.
Bone Marrow Transplantation
|
June 15, 2007
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer
L T Vahdat, D J Cohen, D Zipin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer
A Tiersten, M Selleck, D H Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer
L Vahdat, G Raptis, D Fennelly, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, K Papadopoulos, C Balmaceda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy
A Tiersten, L B Saltz
Oncology Reports
|
May 21, 2011
Acute hypertensive crisis following octreotide administration in a patient with malignant pheochromocytoma
L Saltz, A Tiersten, B Hassan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer
A D Seidman, A Tiersten, C Hudis, et al.
Bone Marrow Transplantation
|
June 15, 2007
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer
L T Vahdat, D J Cohen, D Zipin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer
A Tiersten, M Selleck, D H Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer
L Vahdat, G Raptis, D Fennelly, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Gynecologic Oncology
|
September 5, 2001
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)
M L Rothenberg, P Y Liu, S Wilczynski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, K Papadopoulos, C Balmaceda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Page
of 1